Clinical Trials on Recurrent Prostate Cancer in Australia
Total 1995 results
-
Medical University of ViennaActive, not recruitingProstate Cancer RecurrentAustria
-
Royal North Shore HospitalRecruitingLocally Recurrent Prostate CancerAustralia
-
Medical University of ViennaRecruiting
-
Telix Pharmaceuticals (Innovations) Pty LimitedCompletedMetastatic Prostate CancerAustralia
-
DendreonCompletedProstate Cancer | Prostate Neoplasms | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Cancer of ProstateAustria, France, Netherlands, United Kingdom
-
Telix International Pty LtdCompletedMetastatic Prostate CancerAustralia
-
St Vincent's Hospital, SydneyRecruitingMetastatic Prostate CancerAustralia
-
St Vincent's Hospital, SydneyRecruitingCastration-resistant Prostate Cancer | Homologous Recombination DeficiencyAustralia
-
Genentech, Inc.RecruitingSolid Tumor, Adult | Refractory Cancer | Recurrent CancerAustralia
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
Royal North Shore HospitalTerminatedMetastatic Castrate- Resistant Prostate CancerAustralia
-
Janux TherapeuticsRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | Castration Resistant Prostatic CancerUnited States, Australia
-
Medical University of ViennaCompletedDepressive; Episode, Major | Recurrent Depressive Disorder, Current Episode Moderate | Recurrent Depressive Disorder, Current Episode MildAustria
-
Peter MacCallum Cancer Centre, AustraliaVarian Medical SystemsRecruitingOligometastatic Prostate CancerAustralia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerAustralia
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerAustralia
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
Peter MacCallum Cancer Centre, AustraliaRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
Medical University of ViennaUnknownHormone Refractory Prostate CancerAustria
-
Peter MacCallum Cancer Centre, AustraliaUnited States Department of Defense; Advanced Accelerator Applications; Australian... and other collaboratorsActive, not recruitingMetastatic Hormone Naive Prostate CancerAustralia
-
Novartis PharmaceuticalsTerminatedProstate CancerAustralia
-
Medical University of ViennaRecruitingLocally Advanced and Metastatic Prostate CancerAustria
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
Australian and New Zealand Urogenital and Prostate...Astellas Pharma Inc; Endocyte; Prostate Cancer Research Alliance; National Health...Active, not recruitingMetastatic Castration-Resistant Prostate CancerAustralia
-
Barwon HealthTerminated
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Australian and New Zealand Urogenital and Prostate...Endocyte; Movember Foundation; Australian Nuclear Science and Technology Organisation... and other collaboratorsCompletedMetastatic Cancer | Cancer of the ProstateAustralia
-
Peter MacCallum Cancer Centre, AustraliaCompletedMetastatic Castration Resistant Prostate CancerAustralia
-
EBG MedAustron GmbHRecruitingLow Risk Prostate Cancer | Intermediate Risk Prostate CancerAustria
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
BayerRecruitingBiochemically Recurrent Prostate CancerAustria, Spain, United States, Australia, Brazil, France, Germany, Taiwan, Denmark, China, Netherlands, Portugal, Japan, Canada, Finland, Italy, Hungary, United Kingdom, Poland, Israel, New Zealand, Sweden, Belgium, Czechia
-
Royal North Shore HospitalCompleted
-
St George Hospital, AustraliaRecruiting
-
Royal North Shore HospitalUniversity of SydneyCompleted
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Progen PharmaceuticalsAventis Pharmaceuticals; Northern Sydney and Central Coast Area Health ServiceCompleted
-
Biotech Equity Partners Pty LtdUnknownProstate CancerAustralia
-
Hinova Pharmaceuticals Aus Pty LtdCompletedMetastatic Castration-resistant Prostate CancerAustralia
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
Royal North Shore HospitalWithdrawn
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Amunix, a Sanofi CompanyRecruitingHormone-refractory Prostate CancerAustralia, Spain, United Kingdom
-
ProteoMediX AGCompletedIndication for Prostate Biopsy Due to Suspected Prostate CancerAustria, Germany, Denmark
-
Royal North Shore HospitalCompletedCancer of the ProstateAustralia
-
University of SydneyTrans Tasman Radiation Oncology GroupUnknownProstate CancerAustralia
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Austin HealthCompleted
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
Macquarie University, AustraliaUnknown
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria